Provider
bc-com-pharmprogpolicynotifctn-final-2.8.23-eff-4.1.23.pdf
Search Results
Displaying 1561 - 1570 of 4139 results
Provider
QP6-23 Commercial Pharmacy Benefit Exclusion for Briumvi™, Hemgenix®, Rebyota™, and Sunlenca® Injection
Program effective Date: Feb 08, 2023
Provider
QP7-23 MHCP Pharmacy Benefit Exclusion for Briumvi™, Hemgenix®, Lunsumio™, Rebyota™, Sunlenca® Injection, and Vivimusta
Program effective Date: Feb 08, 2023
Provider
QP8-23 Commercial Formulary Addition for Growth Hormone Therapeutic Class: Genotropin® (somatropin)
Program effective Date: Feb 08, 2023
Provider
QP9-23 Commercial Pharmacy Benefit Exclusion for Select Medications
Program effective Date: Feb 08, 2023
Provider
P77R1-22 Update: New Medical, Medical Drug and Behavioral Health Policy Management Updates: Effective January 30, 2023
Program effective Date: Feb 01, 2023
Provider
P6-23 eviCore Healthcare Specialty Utilization Management (UM) Program: Sleep Management Clinical Guideline Updates
Program effective Date: Feb 01, 2023
Provider
P7-23 Updated Minnesota Health Care Programs (MHCP) and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Program effective Date: Feb 01, 2023